Cognasse F, Osselaer J C, Garraud O
EFS Auvergne-Loire, and GIMAP-EA3064, faculté de médecine, université de Saint-Etienne, 15 rue Ambroise-Paré, 42023 Saint-Etienne cedex 2, France.
Transfus Clin Biol. 2007 May;14(1):69-78. doi: 10.1016/j.tracli.2007.04.009. Epub 2007 May 11.
Platelets have long been confined to haemostasis only. However, novel functions for platelets have been identified recently. Those non-nucleated cells indeed participate to inflammation and also they produce and release numerous factors with known immunomodulatory functions. Among those factors are cytokines and chemokines and the like, such as soluble CD40-Ligand (CD154), which are key molecules in that they bridge innate and adaptative immunity; sCD40L is active on T cells, B cells, monocytes and macrophages, dendritic cells and endothelial cells lining the blood vessels. This means that when a platelet concentrate is transfused to a recipient, a huge amount of cytokines and chemokines is also infused. In this state of the art review, we will present arguments on the role of platelet secretory products in modulating cellular parameters of immunity, and--very likely--in altering functions of those immune cells upon encounters while infusing platelets in blood recipients. We aimed at summarizing data that have been made available on the issue of cytokines/chemokines released by stored platelets prior to delivery. We will focus on the suspected role of the CD40/CD40L tandem in postplatelet transfusion reactions or incidents. We will present recent data on the role of pathogen inactivators on the docking and/or release of cytokines/chemokines by platelets.
长期以来,血小板一直仅被认为与止血有关。然而,最近发现了血小板的新功能。这些无核细胞确实参与炎症反应,并且它们产生和释放许多具有已知免疫调节功能的因子。这些因子包括细胞因子、趋化因子等,例如可溶性CD40配体(CD154),它们是连接固有免疫和适应性免疫的关键分子;sCD40L在T细胞、B细胞、单核细胞、巨噬细胞、树突状细胞以及血管内皮细胞上具有活性。这意味着当将浓缩血小板输注给受者时,也会输入大量的细胞因子和趋化因子。在本综述中,我们将阐述血小板分泌产物在调节免疫细胞参数方面的作用,并且很可能在向输血受者输注血小板时,这些产物会在免疫细胞相遇时改变其功能。我们旨在总结有关储存血小板在输注前释放细胞因子/趋化因子这一问题的现有数据。我们将重点关注CD40/CD40L串联在血小板输血反应或事件中的可疑作用。我们将展示关于病原体灭活剂对血小板细胞因子/趋化因子对接和/或释放作用的最新数据。